Improving Goals of Care Conversations Between Doctors and Young Adults With Cancer
Adaptation of an Evidence-based Goals of Care Communication Intervention for Adolescent and Young Adult Cancer Patients (AYAC)
1 other identifier
interventional
118
1 country
7
Brief Summary
The purpose of this study is to adapt a goals of care communication tool, called Jumpstart, for adolescent and young adult cancer patients (also called AYAC). Goals of care conversations are discussions between patients and their doctors about the patient's wishes, values, and priorities for their care. The Jumpstart tool was created for adult patients to help start these conversations during doctor's appointments. This study will adapt the tool so that it works better for adolescent and young adult patients with cancer. We will also look at whether the tool is practical and useful for AYAC and for medical doctors who see or treat AYAC patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Sep 2026
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2026
CompletedFirst Submitted
Initial submission to the registry
September 28, 2026
CompletedFirst Posted
Study publicly available on registry
October 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 25, 2028
October 2, 2026
September 1, 2026
2 years
September 28, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants who participate
All participants with data will be evaluable for analysis of feasibility (i.e., measures of enrollment and data collection).
2 years
Study Arms (4)
Patients (Adolescent and young adult cancer patients (AYAC) between ages 15-39) on the Jumpstart Arm
EXPERIMENTALPatients on the SOC/Control Arm
ACTIVE COMPARATORClinicians on the Jumpstart Arm
EXPERIMENTALClinicans on the SOC/Control Arm
ACTIVE COMPARATORInterventions
1. Patient-facing survey; 2. GOCC tips sheet for the patient; 3. GOCC guide for providers
Eligibility Criteria
You may qualify if:
- Patient (All Aims)
- Between ages 18-39;
- Has a diagnosis of Stage III or IV cancer as per clinician note in the EMR;
- Attended at least one, but no more than three, appointments with their oncologist as per EMR or self-report;
- English as their primary language in the EMR;
- Can independently consent to study procedures without a surrogate or legally authorized representative;
- MSK treating oncologist answers "no" to the question, "Would you be surprised if this patient died within the next year?"
- AIMS 2 \& 3 ONLY: Did not participate in previous aims Clinician (All Aims)
- are 18 or older;
- are an MSK oncologist who sees AYAC patients
- AIMS 2 \& 3 ONLY: Did not participate in previous aims
You may not qualify if:
- Clinician (Aims 1 \& 2): none
- Patient (Aim 3 ONLY)
- if a GOCC has previously been documented in the EMR
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Memorial Sloan Kettering at Basking Ridge (All protocol activities)
Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack, New York, 11725, United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York, 11553, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Meghan McDarby, PhD
Memorial Sloan Kettering Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2026
First Posted
October 2, 2026
Study Start
September 25, 2026
Primary Completion (Estimated)
September 25, 2028
Study Completion (Estimated)
September 25, 2028
Last Updated
October 2, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.